BioNTech, the German developer of a widely used mRNA vaccine for the coronavirus, agreed to pay US$800 million (HK$6.24 billion) to buy biotech company Biotheus, a developer of cancer drugs. In a statement on Wednesday, Mainz-based BioNTech said it signed a definitive agreement to pay mostly cash for 100 per cent of Biotheus, which is … Read more
The National People’s Congress (NPC) Standing Committee, China’s top legislative body, will convene in Beijing on Monday to discuss a wide range of issues. A large fiscal stimulus, recommended by several prominent economists and hotly anticipated by investors, is likely to be among them. As markets speculate over the potential size of a fiscal package … Read more
China’s World Internet Conference (WIC), an annual event that promotes the Chinese model and concept of internet governance, will focus on artificial intelligence (AI) this year, as Beijing seeks a greater role in the global governance of AI. The event, also known as the Wuzhen Summit, will run from November 19-22 under the theme of … Read more
Should the EU protect European firms by restricting imports of solar technology from China? Drawing on new research, Pia Andres finds that Chinese competition has resulted in many European firms going out of business, but some of those that have survived have adapted by innovating more intensely. Renewable energy is key to enabling the transition … Read more
Seasoned former diplomat Kishore Mahbubani is a distinguished fellow at the National University of Singapore’s Asia Research Institute and author of nine books, including Has China Won? This interview first appeared in SCMP Plus. For other interviews in the Open Questions series, click here. You’ve predicted that the geopolitical contest between the US and China … Read more
